Atlas Trials

Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.

Clinical trial NCT02225977 · COMPLETED

Trial details

NCT number
NCT02225977
Sponsor
University of Southern California
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2013-07-31
Primary completion
2016-12-31
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.